Sepsis Clinical Trials in Baltimore, Maryland

6 studies are recruiting for sepsis in Baltimore, Maryland right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

   This study will enroll adults aged 18 to 80 years diagnosed with sepsis due to a suspected or confirmed bacterial infection, within 7 days of being admitted to the hospital, and who have also developed acute kidney injury within 72 hours of the onset of sepsis. Eligible participants will be randoml…

   Stage

   Phase 2

   Ages

   18 to 80

   Site

   Research Site, Baltimore, Maryland

   Locations

   74 in total

   Run by

   AstraZeneca

   See if you can join NCT07215702 on ClinicalTrials.gov

2. UMMS Sepsis Early Prediction Score (SEPSys) and RESCUE Score Combined Clinical Trial

   This study is designed to test two new risk scores - one designed to predict a patient's four-hour risk of developing sepsis and one designed to predict a patient's four-hour risk of deterioration (cardiac arrest, death, unplanned ICU transfer, or rapid response team call). The goal of this study i…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Maryland Medical Center - Midtown, Baltimore, Maryland

   Locations

   8 in total

   Run by

   University of Maryland, Baltimore

   See if you can join NCT06779617 on ClinicalTrials.gov

3. The APS Phenotyping Study

   The goal of the observational APS phenotyping study is to better understand risk factors, potential biomarkers, length and severity of illness, and recovery for adults with ARDS, pneumonia, and/ or sepsis. This study will also generate a biobank of specimens collected from these patients that will …

   Stage

   Not phased

   Ages

   18 and older

   Site

   Johns Hopkins Univeristy, Baltimore, Maryland

   Locations

   20 in total

   Run by

   Vanderbilt University Medical Center

   See if you can join NCT06521502 on ClinicalTrials.gov

4. Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis

   The goal of this quasi-experimental interventional study is to determine the effectiveness of a multifaceted stewardship intervention in reducing overall vancomycin use in five tertiary care Pediatric Intensive Care Units (PICU). There are two groups of subjects in this study: PICU clinicians/sepsi…

   Stage

   Not phased

   Ages

   Any age

   Site

   Johns Hopkins Children's Center, Baltimore, Maryland

   Locations

   4 in total

   Run by

   Children's Hospital of Philadelphia

   See if you can join NCT05975671 on ClinicalTrials.gov

5. Change in MAPSE During Treatment of Sepsis

   Patients with bloodstream infections (sepsis) have been found in prior studies to have infection-related heart dysfunction, even if they did not have preexisting heart problems. Factors related to the infection may cause the heart to not pump as well as it should, causing critical illness in the fo…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Maryland Medical Center, Baltimore, Maryland

   Run by

   University of Maryland, Baltimore

   See if you can join NCT05634733 on ClinicalTrials.gov

6. TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections

   A pre/post interventional use trial, with ED patients who are initially triaged to locations other than a dedicated patient room in the main ED (e.g., waiting room, hallway bed, and/or the staging area/fast track area) with suspected infection and tachycardia or fever will be enrolled. Study conduc…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Johns Hopkins Department of Emergency Medicine, Baltimore, Maryland

   Locations

   2 in total

   Run by

   Inflammatix

   See if you can join NCT06637904 on ClinicalTrials.gov